Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 22 for “"BT549"”.

  1. SMYD3: A PLAYER IN STEMNESS AND CHROMOSOME INSTABILITY IN TRIPLE NEGATIVE BREAST CANCER

    … cellule di formare sferoidi. Invece, nelle BT549, il KO di SMYD3 determina una diminuzione solo della proliferazione e della capa-cità migratoria. Risultati di sequenziamento dell’RNA da sferoidi primari di MDA-MB-231 hanno rivelato un possibile coinvolgimento di SMYD3 nel pathway di …

    milano Repository record for SMYD3: A PLAYER IN STEMNESS AND CHROMOSOME INSTABILITY IN TRIPLE NEGATIVE BREAST CANCER (opens in a new tab) Embargoed

  2. Collateral Sensitivity Associated with Multidrug-Resistance Protein 5 in Triple-Negative Breast Cancer

    … and TNBC cells (endogenously in MDA-MB-231 and BT549 cells) was associated with increased olaparib sensitivity. This vulnerability was not reversed by a model ABCC5 inhibitor benzbromarone. The low ABCC5 expression level in isogenic parental HEK293 and KO TNBC cells was associated with an …

    auckland-tech Repository record for Collateral Sensitivity Associated with Multidrug-Resistance Protein 5 in Triple-Negative Breast Cancer (opens in a new tab)

  3. The role of Salmonella Typhimurium and microbiome-derived metabolites in tumour regression

    … for progression and metastasis: breast cancer (BT549), prostate cancer (PC-3) and the melanoma cell line B16F10 which has previously been used to evaluate anti-cancer activity in Salmonella. We evaluated the tumour suppressive activity of the metabolites, 4-TMAP and 3M-4-TMAB separately and in …

    glasgow Repository record for The role of Salmonella Typhimurium and microbiome-derived metabolites in tumour regression (opens in a new tab)

  4. A Role for the Phosphoinositide Lipid Kinase PI4KIIIbeta in Breast Oncogenesis and Akt Activation

    … an invasive breast ductal carcinomas cell line, BT549, increased the production of filopodial actin filament protrusions and enhanced in vitro proliferative capacity. Enhanced PI4KIIIβ expression did not impact the migratory rate of these breast cancer cells. We found that PI4KIIIβ expression …

    ottawa-retro Repository record for A Role for the Phosphoinositide Lipid Kinase PI4KIIIbeta in Breast Oncogenesis and Akt Activation (opens in a new tab)

  5. The Potential of CRISPR/Cas9 to Generate SPAG5 Knockout Breast Cancer Cell Lines

    … breast cancer cell lines MCF-7 and BT549. To determine the successful generation of SPAG5 knockout BT549 and MCF-7 cell lines, the goal of this thesis was to perform PCR, western blotting and DNA sequencing and analyse the results. Due to COVID-19 lockdowns, and extended …

    auckland-tech Repository record for The Potential of CRISPR/Cas9 to Generate SPAG5 Knockout Breast Cancer Cell Lines (opens in a new tab)

  6. THE FUNCTIONAL ROLE OF RNA BINDING PROTEIN RBMS3 AS A TUMOR PROMOTER IN TRIPLE-NEGATIVE BREAST CANCER CELLS

    … CSC markers. Conversely, loss of RBMS3 in TNBC BT549 cells inhibits cell proliferation, migration and mesenchymal phenotype. Correlation analysis shows RBMS3 is associated with TGF-β signaling. Mechanistically, RBMS3 interacts with Smad2, Smad3 and Smad4 mRNA and regulates the stability of these …

    uky-thes Repository record for THE FUNCTIONAL ROLE OF RNA BINDING PROTEIN RBMS3 AS A TUMOR PROMOTER IN TRIPLE-NEGATIVE BREAST CANCER CELLS (opens in a new tab)

  7. SUMOYLATION OF NEMO AND NF-KB ACTIVATION BY AN RNA HELICASE, DP103 DEFINES THE METASTATIC POTENTIAL OF HUMAN BREAST CANCERS

    … highly metastatic cell lines like MDA-MB-231 and BT549 display high expression levels of MMP9 and are highly correlated to DP103 levels. We next show via EMSA and luciferase reporter assay that decrease in MMP9 levels is regulated by NF-¿B and not AP-1. Additionally, under the stimulation of known …

    nus Repository record for SUMOYLATION OF NEMO AND NF-KB ACTIVATION BY AN RNA HELICASE, DP103 DEFINES THE METASTATIC POTENTIAL OF HUMAN BREAST CANCERS (opens in a new tab) Download file for SUMOYLATION OF NEMO AND NF-KB ACTIVATION BY AN RNA HELICASE, DP103 DEFINES THE METASTATIC POTENTIAL OF HUMAN BREAST CANCERS (opens in a new tab)

  8. Deep learning-based classification of breast cancer cells using transmembrane receptor dynamics

    … (triple-negative, TN), MDA-MB-231 (TN), and BT549 (TN). The model successfully classified the trajectories into individual cell lines with 83% accuracy and predicted the cell line’s receptor status with 85% accuracy. To test the capability of the trained neural network, epithelial-mesenchymal …

    texas Repository record for Deep learning-based classification of breast cancer cells using transmembrane receptor dynamics (opens in a new tab)

  9. Investigating the molecular mechanism of ERp29-regulated cell cycle arrest in breast cancer

    … three proliferative breast cancer cell lines -- BT549, MDA-MB-231 and SKBR3, suggesting its potential as a marker of tumor aggressiveness. P58ipk was also markedly increased, and appeared to inhibit eIF2alpha phosphorylation. Silencing of eIF2alpha in ERp29-overexpressed MDA-MB-231 cells …

    nus Repository record for Investigating the molecular mechanism of ERp29-regulated cell cycle arrest in breast cancer (opens in a new tab) Download file for Investigating the molecular mechanism of ERp29-regulated cell cycle arrest in breast cancer (opens in a new tab)

  10. Investigating The Effects of Silencing Epha2 In Metastatic Breast Cancer Cells

    … of the overexpressing cell lines, including BT549, MDA-MB-231, and HCC 1954 were selected for experiments utilizing siRNA for transient knockdown and shRNA for stable knockdown. Targeted knockdown of EphA2 was measured using RT-PCR and immunoblotting techniques. Here, the functions of EphA2 …

    uthsc Repository record for Investigating The Effects of Silencing Epha2 In Metastatic Breast Cancer Cells (opens in a new tab)

  11. Function of the PDLIM2 protein in oncogenic Wnt signalling pathways

    … levels in the triple negative breast cancer cell BT549 suggests that PDLIM2 is part of a more complex mechanism that involves transcription and posttranslational modifications. GST pulldown studies and subsequent mass spectrometry analysis showed that PDLIM2 interacts with 300 proteins, with a …

    cork Repository record for Function of the PDLIM2 protein in oncogenic Wnt signalling pathways (opens in a new tab)

  12. ssDNA Nanotubes as a Targeted Drug Delivery Vehicle for Triple Negative Breast Cancer

    … TNBC cell lines: Sum159, MDA-MB-231, and BT549. Interestingly, the nanotubes showed minimal internalization in healthy Hs578Bst cells, suggesting an inherent targeting ability. Inhibition of different internalization mechanisms showed that the nanotubes internalized in the TNBC cells …

    jhu Repository record for ssDNA Nanotubes as a Targeted Drug Delivery Vehicle for Triple Negative Breast Cancer (opens in a new tab)

  13. Identification and Characterization of Novel Kinases Regulating Programmed Death Ligand-1 (PD-L1) in Immune Evasion of Triple Negative Breast Cancer Cells

    … levels. Most significantly, knockout of FAK in BT549 TNBC cells reduces immune evasion by inhibiting cancer cells-induced T-cell apoptosis in coculture experiments. In summary, we have identified several novel kinase regulators of PD-L1 stability and immune evasion. This is a critical first step …

    queens Repository record for Identification and Characterization of Novel Kinases Regulating Programmed Death Ligand-1 (PD-L1) in Immune Evasion of Triple Negative Breast Cancer Cells (opens in a new tab)

  14. Development of a Strategy to Neutralize CCL8 Activity and Ablate CCL8 Cellular Targets

    … tumor volumes in xenografts established with BT549 and MDA-MB-231 cells. In NSG mice bearing patient-derived xenografts of triple-negative breast cancer, both DTCCL2 and DTCCL8 produced significant tumor suppression. Across all in vivo models, cultured tumor explants stained with DAPI showed …

    south-carolina Repository record for Development of a Strategy to Neutralize CCL8 Activity and Ablate CCL8 Cellular Targets (opens in a new tab)

  15. Targeting Vulnerabilities in RB-deficient Breast Cancer

    … growth of the TP53/RB1/PTEN-deficient TNBC line BT549 in immune-compromised NSG mice (Chapter 3). In addition to MPT, Rb-loss also downregulated immune hallmarks including interferon alpha/gamma, inflammation, complement, allograft rejection and IL6 JAK STAT3 signaling. Furthermore, analysis of …

    toronto-retro Repository record for Targeting Vulnerabilities in RB-deficient Breast Cancer (opens in a new tab)

  16. Μελέτη του λειτουργικού ρόλου του ογκοκατασταλτικού γονιδίου CYLD στον καρκίνο του μαστού

    … its ability to inhibit the aggressive growth of BT549 breast cancer cell line by inducing apoptosis. In addition, the Cyld gene has been placed in the 5% of the major genes, whose expression levels show a significant reduction in subpopulations of breast cancer cases. This dissertation …

    greece Repository record for Μελέτη του λειτουργικού ρόλου του ογκοκατασταλτικού γονιδίου CYLD στον καρκίνο του μαστού (opens in a new tab)

  17. NEW FINDINGS INTO TARGET-DIRECTED MICRORNA DEGRADATION MECHANISM

    … trigger (NREP) for miR-29b-3p in SUM159PT and BT549, proving that this can be an effective strategy to quickly identify TDMD substrates and triggers.

    milano Repository record for NEW FINDINGS INTO TARGET-DIRECTED MICRORNA DEGRADATION MECHANISM (opens in a new tab)

  18. Functional Characterisation of Glycosyltransferase 1 Domain Containing 1 gene in Mammary Carcinoma Cells

    … death of mammary carcinoma cell lines, MCF-7 and BT549. Cell viability assay results showed that GLT1D1 differentially reduced MCF-7 and BT-549 cells viability when grown in low serum and full serum media. It was found that while, GLT1D1 reduced MCF-7 cell viability under both full serum and low …

    auckland-ms Repository record for Functional Characterisation of Glycosyltransferase 1 Domain Containing 1 gene in Mammary Carcinoma Cells (opens in a new tab)

  19. CDCP1 as a biomarker of aggressive phenotype in triple negative breast cancer

    … most highly expressing TNBC lines MDA-MB-231 and BT549, I found a strong impairment of their migration and invasion ability as well as of the vasculogenic mimicry capacity, an aggressiveness feature proper of TNBC, suggesting a role for CDCP1 in TNBC dissemination. Immunohistochemistry analysis of …

    the-open-u Download PDF for CDCP1 as a biomarker of aggressive phenotype in triple negative breast cancer (opens in a new tab)

Page 1 of 2